You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Claims for Patent: 6,068,971


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,068,971
Title: Process for determination of ions in fluids by masking of interfering ions
Abstract:A process and a reagent for the determination of ions in fluids, wherein the influence of these ions on the activity of an enzyme is measured. The ions for example are sodium, potassium, calcium, magnesium, manganese, lithium, lead, zinc, copper, iron or other heavy metals or non-metallic ions comprising chloride, bicarbonate, protons, ammonium and substances that give rise to ammonium. The enzymes which are used may be a transferase, a hydrolase, an oxidoreductase or a lyase. An essential feature is a method to exclude interferences by ions by masking the interfering ions with a binding agent.
Inventor(s): Berry; Michael Nathaniel (Eden Hills, AU), Town; Michael-Harold (Oberhausen, DE), Kresse; Georg-Burkhard (Penzberg, DE), Herrmann; Uwe (Bernried, DE)
Assignee: Roche Diagnostics GmbH (Mannheim, DE)
Application Number:07/907,733
Patent Claims:1. A composition for the determination of the concentration of an analyte ion in a fluid sample comprising an enzyme whose activity is stimulated by said analyte ion and is selected from the group consisting of a transferase, a hydrolase, an oxidoreductase or a lyase, and a first selective binding agent that binds to an interfering ion and is present in a quantity sufficient to reduce the concentration of free interfering ion in the fluid sample to insignificant levels.

2. Composition according to claim 1, further comprising the presence of a second selective binding agent, wherein said second selective binding agent binds to said analyte ion in the fluid sample and is present in an amount sufficient to increase the ratio of the activity of the enzyme to the concentration of free analyte ions in the fluid sample to within an optimal range for measurement of the concentration of analyte ion in the fluid sample.

3. Composition according to claim 1 comprising:

4. A composition according to claim 3 which is used at a temperature of 37.degree. C.

5. Composition as claimed in claim 1 comprising:

6. A composition according to claim 5 which is used at a temperature of 37.degree. C.

7. Composition as claimed in claim 1 comprising:

8. A composition according to claim 7 which is used at a temperature of 37.degree. C.

9. Composition as claimed in claim 1 comprising:

10. A composition according to claim 9 which is used at a temperature of 37.degree. C.

11. Process for the determination of the concentration of an analyte ion in a fluid sample, comprising measuring the activity of an enzyme whose activity is stimulated by said analyte ion and is selected from the group consisting of a transferase, a hydrolase, an oxidoreductase or a lyase in the presence of a first selective binding agent that binds to an interfering ion, said first selective binding agent being present in an amount sufficient to reduce the concentration of free interfering ion in the fluid sample to insignificant levels, wherein the measured activity of said enzyme is proportional to the concentration of the analyte ion in the fluid sample.

12. Process according to claim 11, further comprising the presence of a second operative selective binding agent, wherein said second selective binding agent binds to said analyte ion in the fluid sample and is present in an amount sufficient to increase the ratio of the activity of the enzyme to the concentration of free analyte ions in the fluid sample to within an optimal range for measurement of the concentration of analyte ion in the fluid sample.

13. Process according to claim 11, wherein said fluid sample is a body fluid.

14. Process according to claim 13, wherein the analyte ion is selected from the group consisting of potassium, sodium, calcium, magnesium, manganese, lithium, lead, zinc, copper, iron, chloride, or ammonium or substances that give rise to the formation of ammonium.

15. Process according to claims 13, wherein the first selective binding agent is selected from the group consisting of cryptands, coronands, podands, crown ethers, spherands, hemispherands, calixarens, natural occurring ionophores, cyclic peptides, complexones or chelating agents, alkali metals, or alkaline earth metals.

16. Process according to claim 13, wherein said body fluid is selected from the group consisting of blood, serum, plasma, urine, sweat, exudates or transudates.

17. Process according to claim 11, wherein said fluid sample is water.

18. Process according to claim 11, wherein said enzyme is a transferase which transfers phosphorus-containing groups.

19. Process according to claim 18, wherein the transferase is selected from the group consisting of pyruvate kinase, hexokinase, adenylate kinase, pyridoxal kinase or acetate kinase.

20. Process according to claim 11, wherein said enzyme is a hydrolase.

21. Process according to claim 20, wherein the hydrolase is selected from the group consisting of .alpha.- or .beta.-D-galactosidase, carboxypeptidase A, collagenase, amylase, Calpain I, Calpain II, dipeptidyl aminopeptidase I (Cathepsin C) or phosphoglycolate phosphatase.

22. Process according to claim 11, wherein said enzyme is an oxidoreductase.

23. Process according to claim 22, wherein the oxidoreductase is selected from the group consisting of glycerol dehydrogenase, acetaldehyde dehydrogenase or tyrosinase (catechol oxidase).

24. Process according to claim 11, wherein the enzyme is a lyase.

25. Process according to claim 24, wherein the lyase is selected from the group consisting of a carbon-carbon lyase or a carbon-oxygen lyase.

26. Process according to claim 24, wherein the lyase is selected from the group consisting of an aldolase or carbonic anhydrase.

27. Process according to claim 11, wherein said first selective binding agent is selected from the group consisting of cryptands, coronands, podands, crown ethers, spherands, hemispherands, calixarens, natural occurring ionophores, cyclic peptides, complexones or chelating agents, alkali metals, or alkaline earth metals.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.